129 related articles for article (PubMed ID: 1289674)
21. Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
Truong LD; Kadmon D; McCune BK; Flanders KC; Scardino PT; Thompson TC
Hum Pathol; 1993 Jan; 24(1):4-9. PubMed ID: 7678092
[TBL] [Abstract][Full Text] [Related]
22. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta in benign and malignant prostate.
Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
25. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
[TBL] [Abstract][Full Text] [Related]
26. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.
Thompson TC; Timme TL; Kadmon D; Park SH; Egawa S; Yoshida K
Mol Carcinog; 1993; 7(3):165-79. PubMed ID: 8489712
[TBL] [Abstract][Full Text] [Related]
27. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
Wu SF; Sun HZ; Qi XD; Tu ZH
Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
[TBL] [Abstract][Full Text] [Related]
28. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues.
Gerdes MJ; Larsen M; McBride L; Dang TD; Lu B; Rowley DR
J Histochem Cytochem; 1998 Mar; 46(3):379-88. PubMed ID: 9487120
[TBL] [Abstract][Full Text] [Related]
29. Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-beta 1.
Nemeth JA; Sensibar JA; White RR; Zelner DJ; Kim IY; Lee C
Prostate; 1997 Sep; 33(1):64-71. PubMed ID: 9294629
[TBL] [Abstract][Full Text] [Related]
30. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.
Gann PH; Klein KG; Chatterton RT; Ellman AE; Grayhack JT; Nadler RB; Lee C
Prostate; 1999 Sep; 40(4):248-55. PubMed ID: 10420153
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation.
Fitchev PP; Wcislak SM; Lee C; Bergh A; Brendler CB; Stellmach VM; Crawford SE; Mavroudis CD; Cornwell ML; Doll JA
Lab Invest; 2010 Jul; 90(7):1078-90. PubMed ID: 20458281
[TBL] [Abstract][Full Text] [Related]
32. Induction of transforming growth factor beta in hormonally treated human prostate cancer.
Muir GH; Butta A; Shearer RJ; Fisher C; Dearnaley DP; Flanders KC; Sporn MB; Colletta AA
Br J Cancer; 1994 Jan; 69(1):130-4. PubMed ID: 8286194
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
Cohen P; Nunn SE; Peehl DM
J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
[TBL] [Abstract][Full Text] [Related]
34. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
Byrne RL; Leung H; Neal DE
Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
38. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
Lee HR; Hwang KA; Choi KC
Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
[TBL] [Abstract][Full Text] [Related]
39. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
Wong YC; Xie W; Tsao SW
Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
[TBL] [Abstract][Full Text] [Related]
40. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
Kyprianou N; Tu H; Jacobs SC
Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
